Reversible substrate activation and catalysis at an intact metal-metal bond using a redox-active supporting ligand
Talia J Steiman1, Christopher Uyeda1
1Department of Chemistry, Purdue University, West Lafayette, Indiana 47907, United States.
Abstract:
An electron rich Ni(I)-Ni(I) bond supported by a doubly reduced naphthyridine-diimine (NDI) ligand reacts rapidly and reversibly with Ph2SiH2 and Et2SiH2 to form stable adducts. The solid-state structures of these complexes reveal binding modes in which the silanes symmetrically span the Ni-Ni bond and exhibit highly distorted H-Si-H angles and elongated Si-H bonds. This process is facilitated by the release of electron density stored in the π-system of the NDI ligand. Based on this dinuclear mode of activation, [NDI]Ni2 complexes are shown to catalyze the high-yielding hydrosilylation of alkenes, dienes, alkynes, aldehydes, ketones, enones, and amides. In comparative studies of alkyne hydrosilylations, the [NDI]Ni2 catalyst is found to be significantly more active than its mononuclear counterparts for aryl-substituted substrates.
Related Concept Videos
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
Reduction of Alkenes: Asymmetric Catalytic Hydrogenation
The metal catalyst used can be either heterogeneous or homogeneous. When hydrogenation of an alkene generates a chiral center, a pair of enantiomeric products is expected to form. However, an enantiomeric excess of one of the products can be facilitated using an enantioselective reaction or an...
Heterogeneous Catalysis
Introduction to Mechanisms of Enzyme Catalysis
Reduction of Alkynes to cis-Alkenes: Catalytic Hydrogenation
Like alkenes, alkynes can be reduced to alkanes in the presence of transition metal catalysts such as Pt, Pd, or Ni. The reaction involves two sequential syn additions of hydrogen via a cis-alkene intermediate.
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...


